TY - JOUR
T1 - Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity
T2 - An in vitro study using rat and human renal proximal tubular cells
AU - Carvalho, Márcia
AU - Hawksworth, Gabrielle
AU - Milhazes, Nuno
AU - Borges, Fernanda
AU - Monks, Terrence J.
AU - Fernandes, Eduarda
AU - Carvalho, Félix
AU - Bastos, Maria
N1 - Funding Information:
Acknowledgements This work was supported by a project grant from Fundac¸ ão para a Ciência e Tecnologia (FCT; PraxisXXI/BD/ 20087/99) and Programa Operacional Ciência, Tecnologia, Ino-vac¸ ão (POCTI, Portugal), in co-participation with Fonds Européen de Développement Régional (FEDER) European Community funding (project POCTI/36099/FCB/2000).
PY - 2002
Y1 - 2002
N2 - The metabolism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has recently been implicated in the mechanisms underlying ecstasy-induced neurotoxicity and hepatotoxicity. However, its potential role in ecstasy-induced kidney toxicity has yet to be investigated. Thus, primary cultures of rat and human renal proximal tubular cells (PTCs) were used to investigate the cytotoxicity induced by MDMA and its metabolites methylenedioxyamphetamine (MDA), α-methyldopamine (α-MeDA), and the glutathione (GSH) conjugates 5-(glutathion-S-yl)-α-MeDA and 2,5-bis(glutathion-S-yl)-α-MeDA. Cell viability was evaluated using the mitochondrial MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. MDMA and MDA were not found to be toxic to either rat or human PTCs at any concentration tested (100-800 μM). In contrast, 800 μM α-MeDA caused 60% and 40% cell death in rat and human PTCs, respectively. Conjugation of α-MeDA with GSH resulted in the formation of even more potent nephrotoxicants. Thus, exposure of rat and human PTC monolayers to 400 μM 5-(glutathion-S-yl)-α-MeDA caused approximately 80% and 70% cell death, respectively. 5-(Glutathion-S-yl)-α-MeDA (400 μM) was more toxic than 2,5-bis(glutathion-S-yl)-α-MeDA to rat renal PTCs but equally potent in human renal PTCs. Pre-incubation of rat PTCs with either acivicin, an inhibitor of γ-glutamyl transpeptidase (γ-GT), or bestatin, an inhibitor of aminopeptidase M, resulted in increased toxicity of 5-(glutathion-S-yl)-α-MeDA but had no effect on 2,5-bis(glutathion-S-yl)-α-MeDA-mediated cytotoxicity. The present data provide evidence that metabolism is required for the expression of MDMA-induced renal toxicity in vitro. In addition, metabolism of 5-(glutathion-S-yl)-α-MeDA by γ-GT and aminopeptidase M to the corresponding cystein-S-yl-glycine and/or cystein-S-yl conjugates is likely to be associated with detoxication of this compound. Thus, it appears that toxicity induced by thioether metabolites of ecstasy at the apical membrane of renal proximal tubular cells is the result of extracellular events, presumably redox cycling.
AB - The metabolism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has recently been implicated in the mechanisms underlying ecstasy-induced neurotoxicity and hepatotoxicity. However, its potential role in ecstasy-induced kidney toxicity has yet to be investigated. Thus, primary cultures of rat and human renal proximal tubular cells (PTCs) were used to investigate the cytotoxicity induced by MDMA and its metabolites methylenedioxyamphetamine (MDA), α-methyldopamine (α-MeDA), and the glutathione (GSH) conjugates 5-(glutathion-S-yl)-α-MeDA and 2,5-bis(glutathion-S-yl)-α-MeDA. Cell viability was evaluated using the mitochondrial MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. MDMA and MDA were not found to be toxic to either rat or human PTCs at any concentration tested (100-800 μM). In contrast, 800 μM α-MeDA caused 60% and 40% cell death in rat and human PTCs, respectively. Conjugation of α-MeDA with GSH resulted in the formation of even more potent nephrotoxicants. Thus, exposure of rat and human PTC monolayers to 400 μM 5-(glutathion-S-yl)-α-MeDA caused approximately 80% and 70% cell death, respectively. 5-(Glutathion-S-yl)-α-MeDA (400 μM) was more toxic than 2,5-bis(glutathion-S-yl)-α-MeDA to rat renal PTCs but equally potent in human renal PTCs. Pre-incubation of rat PTCs with either acivicin, an inhibitor of γ-glutamyl transpeptidase (γ-GT), or bestatin, an inhibitor of aminopeptidase M, resulted in increased toxicity of 5-(glutathion-S-yl)-α-MeDA but had no effect on 2,5-bis(glutathion-S-yl)-α-MeDA-mediated cytotoxicity. The present data provide evidence that metabolism is required for the expression of MDMA-induced renal toxicity in vitro. In addition, metabolism of 5-(glutathion-S-yl)-α-MeDA by γ-GT and aminopeptidase M to the corresponding cystein-S-yl-glycine and/or cystein-S-yl conjugates is likely to be associated with detoxication of this compound. Thus, it appears that toxicity induced by thioether metabolites of ecstasy at the apical membrane of renal proximal tubular cells is the result of extracellular events, presumably redox cycling.
KW - Human
KW - MDMA
KW - Metabolites, Glutathione conjugate
KW - Rat
KW - Renal proximal tubular cells
UR - https://www.scopus.com/pages/publications/0036390214
UR - https://www.scopus.com/pages/publications/0036390214#tab=citedBy
U2 - 10.1007/s00204-002-0381-3
DO - 10.1007/s00204-002-0381-3
M3 - Article
C2 - 12373454
AN - SCOPUS:0036390214
SN - 0340-5761
VL - 76
SP - 581
EP - 588
JO - Archives of Toxicology
JF - Archives of Toxicology
IS - 10
ER -